medigraphic.com
ISSN 1561-3119 (Electronic)

2012, Number 4

<< Back Next >>

Rev Cubana Pediatr 2012; 84 (4)

Frequency of some genetic diseases in Neuropediatrics

Zaldívar VT, Garófalo GN, Vargas DJ, Rojas ME, Novoa LLM, Bermúdez LV, Martín HI, Viñas PCI

Language: Spanish
References: 19
Page:
PDF size: 114.68 Kb.


ABSTRACT

Introduction: diverse neurological diseases are present in pediatrics and respond to a great number of causes, that is, infectious, genetic, metabolic and degenerative, among others. Within the clinical method in neurology, the genetic diagnosis is related to the etiological diagnosis. There are very few publications that show the frequency of neurogenetic diseases as an etiologic group.
Objective: to describe the frequency of some neuropediatric diseases in the Neurogenetics Service of the Institute of Neurology and Neurosurgery.
Methods: a prospective and descriptive research study was conducted in the 2008-2010 period. The patients were grouped by age and the frequency rate was estimated for infantile spinal muscular atrophy, Dechenne/Becker-type muscular dystrophy, the static lesions of prenatal genetic origin in the central nervous system, and finally for the classification of the groups by the type of inheritance.
Results: the universe of study was composed by 161 patients of whom 72.6 % were males, for a sex ratio of 2.5. The schoolchildren were the majority (37.8 %) and the average age was 5 years. Duchene type muscular dystrophy was the most frequent (24.8 %). Of the total number, 41.40 % was classified as recessive autosomal inheritance. The results agreed with those of the literature.
Conclusions: the hereditary neuromuscular diseases and the static lesions of the central nervous system of prenatal genetic origin are the most common reasons for the request of genetic counseling in the Neurogenetics Service.


REFERENCES

  1. Bird TD. Approaches to the patient with neurogenetic disease. Clin Lab Med. 2010 Dec;30(4):785-93.

  2. Hanna MG, Wood NW. Running a neurogenetic clinic. J Neurol Neurosurg Psychiatry. 2002 Dec;73 Suppl 2:II2-II4.

  3. Müller U, Graeber M, Haberhausen G, Köhler A. Molecular basis and diagnosis of neurogenetic disorders. J Neurol Sci. 1994;124:119-40.

  4. Kerzin-Storrar L, Wright C, Williamson PR, Fryer A, Njindou A, Quarrell O, et al. Comparison of genetic services with and without genetic registers: access and attitudes to genetic counseling services among relatives of genetic clinic patients. J Med Genet. 2002;39:1-5.

  5. Wright C, Kerzin-Storrar L, Williamson PR, Fryer A, Njindou A, Quarrell O, et al. Comparison of genetic services with and without genetic registers: knowledge, adjustment and attitudes about genetic counseling among probands referred to three genetic clinics. J Med Genet. 2002;39:12-9.

  6. Acevedo LA, Zaldivar T, Hernández ChC, Moreno F, Rosich CG, Guerra BR. Enfermedad de Werdnig-Hoffmann. Primer diagnóstico prenatal en Cuba. Rev Neurol. 1999;29(12):1172-5.

  7. Ji X, Liu XQ, Shen JW, Li XH, Tao J. Genetic tests and clinical re-evaluation of 85 children with suspected spinal muscular atrophy. Zhonghua Er Ke Za Zhi. 2010 Jun;48(6):425-30.

  8. Rodríguez M, Ferreira R, Gayol L, Luis R. Caracterización de deleciones en la Distrofia Muscular de Duchenne: su frecuencia en la población cubana. Rev Cub Medicina. 1996;35(2):81-6.

  9. Makitie O. Molecular defects causing skeletal dysplasias. Endocr Dev. 2011;21:78-84.

  10. Gasser T, Trenkwalder C, Meitinger T, Witt TN, Murken J, Oertel WH. Neurogenetics-the challenge for neurology 1. Neurogenetic diseases. Nervenarzt. 1991 Oct;62(10):590-608.

  11. López-Pisón J, Rebage V, Baldellow-Vázquez A, Capablo-Liesa JL, Colomer J, Calvo MT, et al. Hereditary neuromuscualr diaseases in paediatrics. Our experience over the last 14 years. Rev Neurol. 2005;41:145-50.

  12. Jedrzejowska M, Milewski M, Zimowski J, Zagozdzon P, Kostera-Pruszczyk A, Borkowska J, et al. Incidence of spinal muscular atrophy in Poland-more frequent than predicted? Neuroepidemiology. 2010;34(3):152-7.

  13. Sheng-Yuan Z, Xiong F, Chen YJ, Yan TZ, Zeng J, Li L, et al. Molecular characterization of SMN copy number derived from carrier screening and from core families with SMA in a Chinese population. Eur J Hum Genet. 2010 Sep;18(9):978-84.

  14. Su YN, Hung CC, Lin SY, Chen FY, Chern JP, Tsai C, et al. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study. PLoS One. 2011;6(2):e17067.

  15. Verma IC, Saxena R, Lall M, Bijarnia S, Sharma R. Genetic counseling and prenatal diagnosis in India-experience at Sir Ganga Ram Hospital. Indian J Pediatr. 2003 Apr;70(4):293-7.

  16. Verma IC. Burden of genetic disorders in India. Indian J Pediatr. 2000;67(12):893-8.

  17. Austin JC, Palmer CG, Rosen-Sheidley B, Veach PM, Gettig E, Peay HL. Psychiatric disorders in clinical genetics II: Individualizing recurrence risks. J Genet Couns. 2008 Feb;17(1):18-29.

  18. Letourneau MA, MacGregor DL, Dick PT, McCabe EJ, Allen AJ, Chan WL, et al. Use of a telephone nursing line in a pediatric neurology clinic: One approach to the shortage of sub specialists. Pediatrics. 2003;112:1083-7.

  19. Zaldívar T. Bioética y Neurogenética. Cuadernos de Bioética. 2000;XI(43):360-6.




2020     |     www.medigraphic.com